Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

BACKGROUND: Recently, there has been an increased use of recombinant activated factor VII (rFVIIa) to promote hemostasis in various hemorrhagic conditions. The objective of this study was to determine the outcome of patients treated with rFVIIa who had intractable bleeding associated with cardiac su...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Anita, Malkovska, Vera, Catlett, Joseph P, Alcorn, Kirsten
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535534/
https://www.ncbi.nlm.nih.gov/pubmed/15530167
http://dx.doi.org/10.1186/1477-9560-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535534/
https://www.ncbi.nlm.nih.gov/pubmed/15530167
http://dx.doi.org/10.1186/1477-9560-2-9

Ejemplares similares